01525nam 2200433 450 991070725900332120160613090423.0(CKB)5470000002462917(OCoLC)951607615(OCoLC)995470000002462917(EXLCZ)99547000000246291720160613d2014 ua 0engurmn|||||||||rdacontentrdamediardacarrierOIG memorandum reportdrug compendia publishers maintain transparent processes for evaluating anticancer drug therapies and identifying potential conflictsWashington, DC :Department of Health and Human Services, Office of Inspector General,2014.1 online resource (5 pages) illustrationsTitle from title screen (viewed June 13, 2016)."Oct[ober] 30 2014.""OEI-07-13-00220."Includes bibliographical references.OIG memorandum report Medical publishingStandardsUnited StatesConflict of interestsCancerTreatmentUnited StatesEvaluationDrugsUnited StatesTestingMedical publishingStandardsConflict of interests.CancerTreatmentEvaluation.DrugsTesting.GPOGPOBOOK9910707259003321OIG memorandum report3525219UNINA